Qili Shi

270 Dong An Road
Xuhui, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Human messenger RNA harbors widespread noncoding splice isoforms.

Human messenger RNA harbors widespread noncoding splice isoforms.

Journal: Briefings in bioinformatics

Published: October 30, 2025

An SLCO2B1 mRNA Isoform Acts as a Noncoding RNA to Drive Cancer Progression by Triggering Protein Biosynthesis.

An SLCO2B1 mRNA Isoform Acts as a Noncoding RNA to Drive Cancer Progression by Triggering Protein Biosynthesis.

Journal: Cancer research

Published: October 06, 2025

Mitochondrial LINC00942 activates complex I and inhibits ferroptosis through interacting with GRSF1 in liver cancer.

Mitochondrial LINC00942 activates complex I and inhibits ferroptosis through interacting with GRSF1 in liver cancer.

Journal: Science China. Life sciences

Published: July 09, 2025

Correction: The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21.

Correction: The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21.

Journal: Cell death & disease

Published: May 06, 2025

Specific RNA transcripts (SRTs): From concepts to the clinic.

Specific RNA transcripts (SRTs): From concepts to the clinic.

Journal: Chinese medical journal

Published: December 18, 2024

CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription.

CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription.

Journal: Nature communications

Published: December 09, 2024

Glucose-induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma.

Glucose-induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma.

Journal: Clinical and translational medicine

Published: August 12, 2024

The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21.

The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21.

Journal: Cell death & disease

Published: August 12, 2024

Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression.

Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression.

Journal: Oncogene

Published: April 04, 2024

Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer.

Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer.

Journal: Cancer letters

Published: February 22, 2024

Heat shock transcription factor 1 facilitates liver cancer progression by driving super-enhancer-mediated transcription of MYCN.

Heat shock transcription factor 1 facilitates liver cancer progression by driving super-enhancer-mediated transcription of MYCN.

Journal: Cancer medicine

Published: February 20, 2024

MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.

MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.

Journal: Biochemical and biophysical research communications

Published: October 21, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026